[1]罗 君,邵国良,郑家平,等.CT引导下射频消融治疗33例肺癌的回顾性分析[J].介入放射学杂志,2015,(06):530-533.
 LUO Jun,SHAO Guo-liang,ZHENG Jia-ping,et al.CT-guided radiofrequency ablation for lung cancer: a retrospective analysis of 35 cases[J].journal interventional radiology,2015,(06):530-533.
点击复制

CT引导下射频消融治疗33例肺癌的回顾性分析()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2015年06期
页码:
530-533
栏目:
临床研究
出版日期:
2015-06-25

文章信息/Info

Title:
CT-guided radiofrequency ablation for lung cancer: a retrospective analysis of 35 cases
作者:
罗 君 邵国良 郑家平 陈玉堂 姚 征 曾 晖 郝伟远
Author(s):
LUO Jun SHAO Guo-liang ZHENG Jia-ping CHEN Yu-tang YAO Zheng ZENG Hui HAO Wei-yuan
Department of Interventional Radiology, Zhejiang Provincial Cancer Hospital, Zhejiang Provincial Key Laboratory of Chest Tumor (Lung and Esophagus) Diagnosis and Treatment Technology, Hangzhou, Zhejiang Province 310022, China
关键词:
【关键词】 肺癌 射频消融 无进展生存期
文献标志码:
A
摘要:
【摘要】 目的 评价CT引导下射频消融(RFA)治疗肺癌的疗效及安全性。方法 回顾性分析2007年5月至2013年8月接受RFA治疗的33例肺癌患者的35个病灶的治疗情况。所有行RFA的患者术后每3个月随访,以评估疗效和不良反应。随访截止日期为2013年12月或肿瘤出现进展。结果 有完整随访数据的32例肺癌患者的34个病灶消融后1年局部控制率为85.3%。平均1年无进展生存率75.0%,其中15例原发性肺癌的1年无进展生存率为80.0%,17例转移性肺癌为70.6%。总体的中位无进展生存期(mPFS)为(18.0±1.3)个月。不同的年龄、性别、肿瘤大小、病理类型、临床分期等均与患者预期mPFS无显著相关(P>0.05)。RFA的主要不良反应为疼痛、胸腔积液及气胸,未出现危及生命的严重并发症。结论 对早期或是晚期肺癌,RFA都是一种安全有效的微创治疗。

参考文献/References:

[1] Ettinger DS, Akerley W, Borghaei H, et al. Non-small cell lung cancer[J]. J Natl Compr Canc Netw, 2012, 10: 1236-1271.
[2] 蒲德利, 廖江荣. 射频消融联合化疗治疗周围型中晚期非小细胞肺癌疗效观察[J]. 介入放射学杂志, 2013, 22: 129-132.
[3] 刘宝东, 支修益, 刘 磊, 等. CT引导下射频消融治疗中晚期非小细胞肺癌的近期疗效观察[J]. 中国肺癌杂志, 2009, 12: 775-779.
[4] Yamazaki N, Watanabe H, Lu X, et al. Development of a temperature distribution simulator for lung RFA based on air dependence of thermal and electrical properties[J]. Conf Proc IEEE Eng Med Biol Soc, 2012: 5699-5702.
[5] Schoellnast H, Deodhar A, Hsu M, et al. Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy[J]. Acta radiol, 2012, 53: 893-899.
[6] Simon CJ, Dupuy DE, Dipetrillo TA, et al. Pulmonary radiofre-quency ablation: long-term safety and efficacy in 153 patients[J]. Radiology, 2007, 243: 268-275.

相似文献/References:

[1]蒲红.上海市第二届射频消融疑难病例研讨会纪要[J].介入放射学杂志,1997,(01):63.
[2]蒲红,尹炯,王咏梅,等.显性间隔房室旁路的射频消融[J].介入放射学杂志,1997,(02):104.
[3]罗荣光,黄金华.肿瘤射频消融:电极的类型和消融灶的特点[J].介入放射学杂志,2011,(02):159.
 LUO Rong-guang,HUANG Jin-hua..Radiofrequency ablation of tumors: the relationship between the electrode type and the feature of ablated zone[J].journal interventional radiology,2011,(06):159.
[4]程洪涛,郭晨阳,黎海亮,等.TACE联合射频消融治疗原发性肝癌疗效的影响因素分析[J].介入放射学杂志,2012,(03):216.
 ,,et al.TACE combined with CTguided percutaneous radiofrequency ablation for the treatment of primary hepatocellular carcinomas: an analysis of factors affecting the therapeutic result [J].journal interventional radiology,2012,(06):216.
[5]姚红响,陈根生,诸葛英,等.肝动脉化疗栓塞联合CT引导射频消融序贯治疗中小肝癌的临床应用[J].介入放射学杂志,2012,(04):301.
 ,,et al.Sequential treatment with TACE and CTguided RFA for small and moderate sized HCC [J].journal interventional radiology,2012,(06):301.
[6]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗30例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
 ,,et al.TACE combined with radiofrequency ablation for massive primary hepatocellular carcinomas: a clinical therapeutic evaluation [J].journal interventional radiology,2012,(06):322.
[7]朱先海,吕维富,鲁 东,等.超选择性肾动脉栓塞术联合射频消融治疗肾癌的临床应用[J].介入放射学杂志,2011,(07):541.
 ZHU Xian-hai,LV Wei-fu,LU Dong,et al.Superselective renal artery embolization combined with radiofrequency ablation for the treatment of renal carcinomas: evaluation of clinical results[J].journal interventional radiology,2011,(06):541.
[8]谢小西,吕银祥,章宏欣,等. 肝动脉化疗栓塞、射频消融联合125Ⅰ粒子植入 治疗原发性肝癌的临床应用[J].介入放射学杂志,2011,(11):863.
 XIE Xiao-xi,LV Yin-xiang,ZHANG Hong-xin,et al.The clinical application of TACE together with RFA and 125Ⅰ seed implantation in treating hepatocellular carcinoma[J].journal interventional radiology,2011,(06):863.
[9]李建军,郑加生,崔雄伟,等. 肝肿瘤CT引导经皮射频消融术后胆道并发症防治[J].介入放射学杂志,2011,(12):984.
 LI Jian-jun,ZHENG Jia-sheng,CUI Xiong-wei,et al.The prevention and treatment of biliary complications occurred after CT-guided percutaneous radiofrequency ablation for hepatic neoplasms[J].journal interventional radiology,2011,(06):984.
[10]贺克武,高 斌,秦汉林,等. 125I粒子组织间植入联合支气管动脉灌注化疗治疗肺癌的疗效观察[J].介入放射学杂志,2012,(07):554.
 HE Ke- wu,GAO Bin,QIN Han- lin,et al.CT?蛳 guided percutaneous 125I seed implantation combined with bronchial arterial infusion chemotherapy for lung cancers: observation of therapeutic efficacy[J].journal interventional radiology,2012,(06):554.
[11]牛丹丹,万娅敏,周志刚,等.CT灌注联合能谱成像评价射频消融治疗肺癌近期疗效[J].介入放射学杂志,2016,(04):325.
 NIU Dan- dan,WAN Ya- min,ZHOU Zhi- gang,et al.Application of CT perfusion scanning combined with spectral imaging in evaluating the short- term effect of radiofrequency ablation for pulmonary adenocarcinomas[J].journal interventional radiology,2016,(06):325.

备注/Memo

备注/Memo:
(收稿日期:2014 1-2 -09)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2015-06-24